carbamates has been researched along with ro 20683 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, RT; Kovarik, Z; Simeon-Rudolf, V; Skrinjarić-Spoljar, M | 1 |
| Grgas, B; Kovarik, Z; Radić, Z; Reiner, E; Simeon-Rudolf, V; Skrinjarić-Spoljar, M | 1 |
2 other study(ies) available for carbamates and ro 20683
| Article | Year |
|---|---|
An explanation for the different inhibitory characteristics of human serum butyrylcholinesterase phenotypes deriving from inhibition of atypical heterozygotes.
Topics: Apnea; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Dibucaine; Genetic Carrier Screening; Humans; Kinetics; Neuromuscular Depolarizing Agents; Phenotype; Quaternary Ammonium Compounds; Sodium Fluoride; Succinylcholine; Thiocholine | 1999 |
Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
Topics: Acetylcholinesterase; Amino Acids; Animals; Binding Sites; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Humans; Isoleucine; Kinetics; Mice; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Phenylalanine; Protein Conformation; Quaternary Ammonium Compounds; Terbutaline | 1999 |